to investigate the lipoprotein effect of fenofibrate in hypercholesterolemia or combined hyperlipidemia ( types ii a and ii b hyperlipidemias , respectively ) , 240 patients were recruited and 227 randomized to a double-blind randomized trial lasting 24 weeks and 192 patients continued to participate in an open-label phase for another 24 weeks .
C0033228
fenofibrate
C0020443
hypercholesterolemia